Merck Smashes Q1 Earnings Estimate, Boosts 2019 Outlook, as Keytruda Sales Surge

Merck posted stronger-than-expected first quarter earnings Tuesday, and lifted its 2019 profit guidance, as its blockbuster lung cancer treatment topped $2.2 billion.